| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.03 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.04 |